Analgesic Use in Dutch Patients With Osteoarthritis: Frequent But Low Doses.


Journal

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
ISSN: 1536-7355
Titre abrégé: J Clin Rheumatol
Pays: United States
ID NLM: 9518034

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 12 7 2018
medline: 26 2 2020
entrez: 12 7 2018
Statut: ppublish

Résumé

The aim of this study was to examine which analgesics are used by patients with osteoarthritis (OA)-related pain and how the analgesics are used in the preceding month. In addition, their beliefs about (pain) medication and the rationale of those declining to use analgesics were explored. An online cross-sectional survey was sent to 1521 patients participating in the panel of the Dutch Arthritis Foundation. Descriptive analyses and logistic regression were used to analyze data. Of the 842 participants (56%) with OA that responded, 70% had generalized OA, 26% had concomitant fibromyalgia, and 34% had another musculoskeletal morbidity. Of all participants, 71% used analgesics, and 34% used more than 1 type. Analgesics were used for more than 14 days in the preceding month by most participants, with paracetamol being used most frequently (51%). Doses used were predominantly lower than the daily defined dose: 58.2% for paracetamol, 31.2% for nonsteroidal anti-inflammatory drugs/cyclooxygenase-2 inhibitors, and 75.7% for weak opioids. Compared with participants with concomitant fibromyalgia or other musculoskeletal morbidities, participants with OA alone significantly more frequently declined to use analgesics (p < 0.01) and significantly less frequently used 2 or 3 types of analgesics (p < 0.05). In this population with generalized OA and musculoskeletal comorbidities, medication use was high, and more than 1 type of analgesic was frequently used. Patients with concomitant fibromyalgia or other musculoskeletal morbidities more frequently used 2 or 3 types of analgesics; however, this use was often intermittent and in low doses. Medication use on a daily basis and at higher doses may lead to improved analgesic effect.

Identifiants

pubmed: 29994797
doi: 10.1097/RHU.0000000000000853
doi:

Substances chimiques

Analgesics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-303

Auteurs

Jacoline J van den Driest (JJ)

From the Department of General Practice, Erasmus Medical Center, University Medical Center, Rotterdam.

Patrick Pijnenburg (P)

Dutch Arthritis Foundation, Amsterdam.

Patrick J E Bindels (PJE)

From the Department of General Practice, Erasmus Medical Center, University Medical Center, Rotterdam.

Dieuwke Schiphof (D)

From the Department of General Practice, Erasmus Medical Center, University Medical Center, Rotterdam.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH